| Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients EP Krenning, DJ Kwekkeboom, WH Bakker, WAP Breeman, PPM Kooij, ... European journal of nuclear medicine 20, 716-731, 1993 | 2017 | 1993 |
| Octreotide SWJ Lamberts, AJ Van der Lely, WW de Herder, LJ Hofland new england Journal of Medicine 334 (4), 246-254, 1996 | 1478 | 1996 |
| Treatment of adrenocorticotropin-dependent Cushing’s syndrome: a consensus statement BMK Biller, AB Grossman, PM Stewart, S Melmed, X Bertagna, J Bertherat, ... The Journal of Clinical Endocrinology & Metabolism 93 (7), 2454-2462, 2008 | 1072 | 2008 |
| The pathophysiological consequences of somatostatin receptor internalization and resistance LJ Hofland, SWJ Lamberts Endocrine reviews 24 (1), 28-47, 2003 | 563 | 2003 |
| Ghrelin stimulates, whereas des-octanoyl ghrelin inhibits, glucose output by primary hepatocytes C Gauna, PJD Delhanty, LJ Hofland, JA Janssen, F Broglio, RJM Ross, ... The Journal of Clinical Endocrinology & Metabolism 90 (2), 1055-1060, 2005 | 395 | 2005 |
| [111In-DTPA-D-Phe1]-octreotide, a potential radiopharmaceutical for imaging of somatostatin receptor-positive tumors: synthesis, radiolabeling and in vitro validation WH Bakker, R Albert, C Bruns, WAP Breeman, LJ Hofland, P Marbach, ... Life sciences 49 (22), 1583-1591, 1991 | 382 | 1991 |
| The medical treatment of Cushing’s disease: effectiveness of chronic treatment with the dopamine agonist cabergoline in patients unsuccessfully treated by surgery R Pivonello, MC De Martino, P Cappabianca, M De Leo, A Faggiano, ... The Journal of Clinical Endocrinology & Metabolism 94 (1), 223-230, 2009 | 366 | 2009 |
| Administration of acylated ghrelin reduces insulin sensitivity, whereas the combination of acylated plus unacylated ghrelin strongly improves insulin sensitivity C Gauna, FM Meyler, J Janssen, PJD Delhanty, T Abribat, ... The Journal of Clinical Endocrinology & Metabolism 89 (10), 5035-5042, 2004 | 337 | 2004 |
| Comparison of 111In-labeled Somatostatin Analogues for Tumor Scintigraphy and Radionuclide Therapy M de Jong, WAP Breeman, WH Bakker, PPM Kooij, BF Bernard, ... Cancer Research 58 (3), 437-441, 1998 | 337 | 1998 |
| The multi-ligand somatostatin analogue SOM230 inhibits ACTH secretion by cultured human corticotroph adenomas via somatostatin receptor type 5 LJ Hofland, J van der Hoek, R Feelders, MO van Aken, PM van Koetsveld, ... European Journal of Endocrinology 152 (4), 645-654, 2005 | 318 | 2005 |
| Pasireotide alone or with cabergoline and ketoconazole in Cushing's disease RA Feelders, C de Bruin, AM Pereira, JA Romijn, RT Netea-Maier, ... New England Journal of Medicine 362 (19), 1846-1848, 2010 | 312 | 2010 |
| Dopamine receptor expression and function in corticotroph pituitary tumors R Pivonello, D Ferone, WW de Herder, JM Kros, ML Del Basso De Caro, ... The Journal of Clinical Endocrinology & Metabolism 89 (5), 2452-2462, 2004 | 301 | 2004 |
| Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours. WW De Herder, LJ Hofland, AJ van der Lely, SWJ Lamberts Endocrine-related cancer 10 (4), 451-458, 2003 | 271 | 2003 |
| The Novel Somatostatin Analog SOM230 Is a Potent Inhibitor of Hormone Release by Growth Hormone- and Prolactin-Secreting Pituitary Adenomas in Vitro LJ Hofland, J van der Hoek, PM van Koetsveld, WW de Herder, ... The Journal of Clinical Endocrinology & Metabolism 89 (4), 1577-1585, 2004 | 232 | 2004 |
| Parallel in Vivo and in Vitro Detection of Functional Somatostatin Receptors in Human Endocrine Pancreatic Tumors: Consequences with Regard to Diagnosis … SWJ LAMBERTS, LEOJ HOFLAND, PM VAN KOETSVELD, JC REUBI, ... The Journal of Clinical Endocrinology & Metabolism 71 (3), 566-574, 1990 | 229 | 1990 |
| Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells VASH Dalm, PM Van Hagen, PM Van Koetsveld, S Achilefu, ... American Journal of Physiology-Endocrinology and Metabolism 285 (2), E344-E353, 2003 | 217 | 2003 |
| Ghrelin secretion is inhibited by either somatostatin or cortistatin in humans F Broglio, P Koetsveld, A Benso, C Gottero, F Prodam, M Papotti, ... The Journal of Clinical Endocrinology & Metabolism 87 (10), 4829-4832, 2002 | 212 | 2002 |
| Novel insights in dopamine receptor physiology R Pivonello, D Ferone, G Lombardi, A Colao, SWJ Lamberts, LJ Hofland European journal of endocrinology 156 (Supplement_1), S13-S21, 2007 | 204 | 2007 |
| Somatostatin and somatostatin receptors in the immune system: a review. AMC ten Bokum, LJ Hofland, PM van Hagen European cytokine network 11 (2), 161-76, 2000 | 194 | 2000 |
| Ghrelin drives GH secretion during fasting in man AF Muller, SWJ Lamberts, J Janssen, LJ Hofland, P Van Koetsveld, ... European Journal of Endocrinology 146 (2), 203-207, 2002 | 193 | 2002 |